Cover Image
Market Research Report

Nanotechnology in Drug Delivery

Published by Global Industry Analysts, Inc. Product code 297187
Published Content info 151 Pages
Delivery time: 1-2 business days
Price
Back to Top
Nanotechnology in Drug Delivery
Published: October 1, 2018 Content info: 151 Pages
Description

This report analyzes the worldwide markets for Nanotechnology in Drug Delivery in US$ Million. The Global Market is further analyzed by the following Delivery Technologies: Nanocrystals, and Nanocarriers. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2024. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 43 companies including many key and niche players such as -

AbbVie, Inc.
Aquanova AG
BlueWillow Biologics
Camurus AB
Celgene, Inc.
Ceramisphere Health Pty Limited

Table of Contents
Product Code: MCP-7808

Table of Contents

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Data Interpretation & Reporting Level
  • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
  • Nanotechnology and Nanomedicine
  • Nanotechnology in Drug Delivery
  • Nanotechnology Drug Delivery Systems
    • Nanocrystals
    • Nanocarriers

2. OUTLOOK

  • Nanotechnology, A Critical Part of Healthcare Reform
    • Table 1: Reliance On Nanotechnology as a Tool to Increase Quality of Affordable Care Increases as Growing Number of Healthcare Businesses Align Their Operational Goals With Value-Based Reimbursement (VBR) % of VBR & Fee-For-Service Structured Healthcare Organizations for the Years 2016, 2018 and 2022 (includes corresponding Graph/Chart)
  • Nanomedicine, Revolutionizing the Basics of Medicine
  • A Peek Into the Evolving Role of Nanoparticles in Nanomedicine
  • Nanocrystals Continue to Gain Momentum as Alternatives to Traditional Nanocarriers
  • Nanocarriers Enable Targeted Drug Delivery Systems to Improve Therapeutic Outcomes
  • Advanced Liposomes Enable Low Soluble Drugs to Achieve Targeted Delivery
    • List of Marketed Liposome-Based Clinical Products Classified by Therapeutic Areas
  • Multifunctional Dendrimers Present an Ideal Structure for Targeted Drug Delivery
    • List of Commercially Available Dendrimeric Products by Application Area
  • High Drug Loading Capacity of PAMAM Dendrimers Bodes Well for Targeted Drug Delivery Systems
    • Table 2: Growing Global Burden of Cancer Throws the Spotlight on Cancer Nanomedicine Valued for its Sensitive Cancer Detection & Targeted Therapy Delivery: Global Cancer New Incidence & Number of Deaths (in 000s) by Type for the Year 2018 (includes corresponding Graph/Chart)
    • Table 3: Global Cancer New Incidence & Number of Deaths (in 000s) by Geographic Region for the Year 2018 (includes corresponding Graph/Chart)
  • Nanotechnology-Based Strategies for siRNA Grows in Popularity
    • Table 4: Growing Interest in Gene Therapy Drives Opportunities for Nanomaterials to Overcome Challenges of Gene Delivery: Global Cell & Gene Therapy Market (in US$ Million) for the Years 2013, 2019 and 2022 (includes corresponding Graph/Chart)
  • NEM Devices as Drug Delivery Vehicles
  • Nanotechnology - In Pursuit of Co-Delivery of Drugs
  • Nanoemulsions Begin to Make a Mark
  • Growing Need for Alternative Approaches to Conventional Chemotherapy Creates Opportunities for Nanoparticles
  • Stimuli Responsive Polymeric Micelles Promise Enhanced Therapeutic Effect for Hydrophobic Anticancer Drugs
  • Inorganic Nanocarriers Facilitate High Payload Capacity and Co-Delivery Platforms for MDR Cancer Therapy
  • Solid Lipid Nanoparticles Provide Increased Physical Stability in Targeted Drug Delivery
  • Pulmonary Delivery of Nanoparticle-Based Drugs Receives Increased Interest
  • Inhalable Liposome Formulations Attract Research Interest in Pulmonary Delivery
  • SLNs in Pulmonary Delivery of Drugs
    • Other Nanocarriers in Pulmonary Delivery
  • Nanotechnology Finds Increasing Role in Fighting Infectious Diseases
  • List of Select Nanotechnology-based Antimicrobial Drugs in Clinical Use
  • Nanotechnology Opening New Avenues in Antiretroviral Therapy
  • Demonstrated Activity of Select Nanotechnology- Delivered Antiretroviral Therapies
  • Nanotechnology in Delivery of CNS Therapeutics
  • Market Challenges
  • Increasing Environmental and Health Concerns
  • Limited Success and Scaling Up Issues Pose a Major Hurdle to Further Advancement
  • Higher Concentration of Research in Academia limits Commercialization
  • Collaborations Assume Importance
  • Nanomedicine Regulation
  • Market Outlook

3. PRODUCT OVERVIEW

  • Defining Nanotechnology and Nanomedicine
  • Applications of Nanoparticles in Drug Delivery
  • Nanotechnology-Based Drug Delivery Technologies by Segment
  • Nanocrystals
  • Nanocarriers
    • Nanostructures in Drug Delivery
      • Features of a Rational Nanocarrier
      • List of Select Nanomaterials Being Studied or Developed for Drug Delivery
      • Drug Delivery Technologies, Forms and Materials
    • Overview of Select Major Nanocarriers
      • Comparison of Key Attributes of Select Major Nanocarriers
      • Liposomes
      • List of Select Drugs/Compounds Demonstrated for Efficacious Liposome-based Delivery
      • Polymeric Nanoparticles
      • List of Select Drugs Demonstrated for Efficacious Polymeric Nanoparticle-based Delivery
      • Dendrimers
      • List of Select Drugs Demonstrated for Efficacious Dendrimer-based Delivery
      • Solid Lipid Nanoparticles (SLNs)
      • Nanotubes
      • List of Select Drugs Demonstrated for Efficacious Nanotube-based Delivery
      • Polymeric Micelles
      • Nanocapsules
      • Fullerenes
  • Nanostructure Synthesis
  • Top-Down Approach
  • Bottom-Up Approach
  • Requisites for Optimal Nanoparticle Design
  • Size and Surface Charge of the Nanoparticle
  • PEGylation and Ligand Functionalization
    • A Review of Select Nanotechnology-Based Delivery Systems in Anti-Cancer Therapies
      • Albumin - A Key Delivery Vehicle
      • Micellar Nanoparticle Formulation of Paclitaxel
      • Liposomal Formulation of Anti-Cancer Therapies
      • Dendrimers Finding Extending Use in Nanoparticle-based Anti-Cancer Drug Delivery
      • Polymeric Micelles in Cancer Drug Delivery
      • List of Select Nanoparticle Drug Delivery Systems and Uses in Cancer Therapies

4. COMPETITIVE LANDSCAPE

  • 4.1 Focus on Select Players
  • AbbVie Inc. (USA)
  • Aquanova AG (Germany)
  • BlueWillow Biologics (USA)
  • Camurus AB (Sweden)
  • Celgene, Inc. (Canada)
  • Ceramisphere Health Pty Limited (Australia)
  • Cristal Therapeutics (The Netherlands)
  • CYTIMMUNE SCIENCES, INC. (Italy)
  • EnColl Corporation (USA)
  • EyePoint Pharmaceuticals (USA)
  • Lena Nanoceutics Ltd. (UK)
  • NanOlogy LLC (USA)
  • NanoCarrier Co., Ltd. (Japan)
  • Nanobiotix (France)
  • Nanospectra Biosciences, Inc (USA)
  • Parvus Therapeutics Inc. (USA)
  • Selecta Biosciences (USA)
  • Starpharma Holdings Limited (Australia)
  • Taiwan Liposome Co. (Taiwan)
  • Tarveda Therapeutics (USA)
  • 4.2 Recent Industry Activity
  • Alkermes' NDA for ALNCD to Seek Approval from FDA
  • NanoBio Changes Name to BlueWillow Biologics(r)
  • pSivida Acquires Icon Bioscience and Rebrand as EyePoint Pharmaceuticals
  • Ceramisphere Announces Spin-Off of its Ceramisphere Health
  • NanOlogy Launches Trials Evaluating its Nanoparticle Suspension
  • NanoCarrier Collaborates with JCR Pharmaceuticals for Drug Delivery
  • DFB Pharmaceuticals Collaborates with CritiTech and US Biotest and forms NanOlogy
  • Flamel Merges with Avadel

5. GLOBAL MARKET PERSPECTIVE

    • Table 5: World Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2024 (includes corresponding Graph/Chart)
    • Table 6: World 10-Year Perspective for Nanotechnology in Drug Delivery by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2015, 2018 and 2024 (includes corresponding Graph/Chart)
    • Table 7: World Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanocrystals and Nanocarriers Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2024 (includes corresponding Graph/Chart)
    • Table 8: World 10-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Dollar Sales for Nanocrystals and Nanocarriers Markets for Years 2015, 2018 and 2024 (includes corresponding Graph/Chart)

6. REGIONAL MARKET PERSPECTIVE

  • 6.1 The United States
  • A. Market Analysis
    • Current & Future Analysis
    • Market Overview
    • FDA's Regulatory Approach to Nanotechnology Products
      • Few Challenges Faced by FDA
  • B. Market Analytics
    • Table 9: The US Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2024 (includes corresponding Graph/Chart)
  • 6.2 Canada
  • Market Analysis
    • Table 10: Canadian Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2024 (includes corresponding Graph/Chart)
  • 6.3 Japan
  • A. Market Analysis
    • Current & Future Analysis
    • Regulations on Nanomedicine in Japan
  • B. Market Analytics
    • Table 11: Japanese Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2024 (includes corresponding Graph/Chart)
  • 6.4 Europe
  • A. Market Analysis
    • Current & Future Analysis
    • Harmonization Of Regulations - A Key Goal for Ema
  • B. Market Analytics
    • Table 12: European Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2024 (includes corresponding Graph/Chart)
    • Table 13: European 10-Year Perspective for Nanotechnology in Drug Delivery by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2018 and 2024 (includes corresponding Graph/Chart)
  • 6.4.1 France
  • A. Market Analysis
    • Current & Future Analysis
    • Regulations on Nanomaterials
  • B. Market Analytics
    • Table 14: French Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2024 (includes corresponding Graph/Chart)
  • 6.4.2 Germany
  • A. Market Analysis
    • Current & Future Analysis
    • Germany - A Regional Hub for Nanomedicine Research
  • B. Market Analytics
    • Table 15: German Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2024 (includes corresponding Graph/Chart)
  • 6.4.3 Italy
  • Market Analysis
    • Table 16: Italian Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2024 (includes corresponding Graph/Chart)
  • 6.4.4 The United Kingdom
  • Market Analysis
    • Table 17: UK Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2024 (includes corresponding Graph/Chart)
  • 6.4.5 Spain
  • Market Analysis
    • Table 18: Spanish Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2024 (includes corresponding Graph/Chart)
  • 6.4.6 Russia
  • Market Analysis
    • Table 19: Russian Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2024 (includes corresponding Graph/Chart)
  • 6.4.7 Rest of Europe
  • Market Analysis
    • Table 20: Rest of Europe Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2024 (includes corresponding Graph/Chart)
  • 6.5 Asia-Pacific
  • Market Analysis
    • Table 21: Asia-Pacific Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Geographic Region - China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2024 (includes corresponding Graph/Chart)
    • Table 22: Asia-Pacific 10-Year Perspective for Nanotechnology in Drug Delivery by Geographic Region - Percentage Breakdown of Dollar Sales for China and Rest of Asia-Pacific Markets for Years 2015, 2018 and 2024 (includes corresponding Graph/Chart)
  • 6.5.1 China
  • A. Market Analysis
    • Current & Future Analysis
    • New Findings Reinforce Role of Silica Nanoparticles in Drug Delivery and Diagnostics
    • Nanotechnology Patent Profile in China
  • B. Market Analytics
    • Table 23: Chinese Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2024 (includes corresponding Graph/Chart)
  • 6.5.2 Rest of Asia-Pacific
  • A. Market Analysis
    • Current & Future Analysis
    • Indian Nanotechnology Market - An Overview
  • B. Market Analytics
    • Table 24: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2024 (includes corresponding Graph/Chart)
  • 6.6 Latin America
  • Market Analysis
    • Table 25: Latin American Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2024 (includes corresponding Graph/Chart)
  • 6.7 Rest of World
  • Market Analysis
    • Table 26: Rest of World Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2024 (includes corresponding Graph/Chart)

7. COMPANY PROFILES

  • Total Companies Profiled: 43 The United States (19) Canada (1) Japan (2) Europe (14) - France (3) - Germany (2) - The United Kingdom (4) - Rest of Europe (5) Asia-Pacific (Excluding Japan) (7)
Back to Top